SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-132916
Filing Date
2019-05-01
Accepted
2019-05-01 16:05:32
Documents
1
Period of Report
2019-05-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d739811d8k.htm 8-K 13059
  Complete submission text file 0001193125-19-132916.txt   14223
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 19787422
SIC: 2834 Pharmaceutical Preparations